Industries > Pharma > Meningococcal Vaccines Market Report 2021-2031
Meningococcal Vaccines Market Report 2021-2031
Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
Global Meningococcal Vaccines Market 2021-2031 – our new study reveals latest industry trends, R&D progress, and predicted revenues
Visiongain understands that the Global Meningococcal Vaccines Market will register robust growth. Increasing prevalence of meningitis, increasing initiatives by government and regulatory authorities, presence of non-profit organizations providing funds for research projects and vaccine trials and are expected to commercialized during the forecast period consequently driving the meningococcal vaccines market by 2031. Meningococcal vaccines market is highly competitive with presence of well-established players with limited scope of regional manufacturers for vaccine platforms. Although, the meningococcal vaccine market will exhibit significant growth during the forecast period, increasing inclusion in NIPs (National Immunization Programs) is unlocking new window of opportunities for meningococcal vaccines worldwide.
Conjugate Segment valued US$x million in 2021 is set to grow at a CAGR of xx% from 2021-2031. Owing to its key benefits such as longer lasting immunity along with its capability to bring herd immunity continues to drive the growth of this segment. Additionally, many key players have several meningococcal conjugate vaccine products in their pipeline and is expected to have significant opportunities for the growth during the forecast period.
By end user, the pediatric segment accounted for the largest market share of 66% in 2021 and is poised to foresee rapid growth during the forecast period due to upsurge in adoption of meningococcal vaccine in several countries across the globe as a part of national immunization programs.
North America continues to retain its hold on meningococcal vaccines market and accounted to have the largest market of 44.2% in 2021. Well-established healthcare infrastructure, developed economy, presence of leading pharmaceutical industry are major factors responsible for sustained growth in this region. The Asian region is expected to foresee the highest growth of 7.3% during the forecast period owing various factors such as increasing healthcare expenditure, increasing disposable income, government initiatives, and the presence of a large patient population. Our report keeps you informed and up to date with latest developments across geographies including North America, Europe, Asia, Latin America and Middle East and Africa.
The report also captures information pertaining to latest mergers & acquisitions, technological innovations, geographical expansion plans of all the leading players of this industry. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
The report provides in-depth information of key investment trends in global meningococcal vaccines market, subdivided by type of vaccines type, end user and vaccine brand.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
This report will answer questions such as:
• What is the meningococcal vaccines market status in 2021 and how it will evolve through 2031?
• What are the drivers, restraints, and opportunities of the meningococcal vaccines market?
• How will each meningococcal vaccines submarket segment grow over the forecast period and how much revenue will each segment account for in 2031?
• How will individual leading national markets perform over the forecast period, and what are their drivers and restraints?
• What have been the major developments of the leading national markets for meningococcal vaccines market over recent years, leading to their current market status?
• How will the market shares of the regional and leading national markets evolve by 2031, and which geographical region will lead in 2031?
Reasons Why You Must Order and Read This Report Today:
The Report provides Meningococcal Vaccines Market By Vaccine Type
• Conjugate
• Polysaccharide
• Others
The Report provides Meningococcal Vaccines Market By End User
• Pediatric
• Adult
• Travelers
The Report provides Meningococcal Vaccines Products Market By Vaccine Brand
• Bexsero
• Menactra
• Menveo
• Others
Report Covers Regional Analysis
North America meningococcal vaccines Market
• US meningococcal vaccines Market
• Canada meningococcal vaccines Market
Europe meningococcal vaccines Market
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
Asia meningococcal vaccines Market
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia
Latin America meningococcal vaccines Market
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa meningococcal vaccines Market
• GCC
• South Africa
• Rest of Latin America
Need industry data? Please contact us today.
The report provides detailed profiles of the leading companies operating within the Meningococcal Vaccines market:
• Sanofi, Merck & Co., Inc.
• GlaxoSmithKline plc.
• Pfizer Inc.
• Serum Institute of India Pvt. Ltd.
• Zhi Fei Biological
• Hualan Biological Engineering Inc
• Incepta Pharmaceuticals Ltd.
• Walvax Biotechnology Co., Ltd.
• BIO-MED
• JN International Medical Corporation
Our report captures in-depth analysis of meningococcal vaccines market within total 374 pages with 256 tables and 255 figures. The study helps all the stakeholders to discover and understand this lucrative meningococcal vaccines market with respect to financial results, trends, opportunities and identify business opportunities.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Meningococcal Vaccines Market
1.2 Meningococcal Vaccines Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Increasing prevalence of meningitis
3.1.2 Increasing initiatives by government and regulatory authorities
3.1.3 Presence of Non-profit Organizations Providing funds for research projects
3.1.4 Vaccine trials and are expected to commercialized during the forecast period
3.2 Restraints
3.2.1 Low Production rate and high cost
3.2.2 High Costs of Drug Development Limits the Entry of New Players
3.2.3 Long Vaccine Manufacturing Timelines to Impede the Growth of the Vaccines Market
3.3 Opportunities
3.3.1 Increasing Inclusion in NIPs Unlocking New Windows of Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier: Moderate
3.4.2 Bargaining Power of Buyer: Moderate
3.4.3 Competitive Rivalry: High
3.4.4 Threat of New Entrants: low
3.4.5 Threat of Substitutes: Low
3.5 PEST Analysis
3.5.1 Political Factors Impacting Meningococcal Vaccines Market
3.5.2 Economic Factors Impacting Meningococcal Vaccines Market
3.5.3 Social Factors Impacting Meningococcal Vaccines Market
3.5.4 Technological Factors Impacting Meningococcal Vaccines Market
4 Meningococcal Vaccines Market by Vaccine Type Forecast, 2021-2031
4.1 Conjugate Segment Market Forecast, 2021-2031
4.1.1 Increasing investment of Government and Private sectors in the development of conjugate Vaccines
4.1.2 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.2 Polysaccharide Segment Market Forecast, 2021-2031
4.2.1 Polysaccharide Vaccines is expected to hold Largest Market Share over the forecast period
4.2.2 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.3 Other Segment Market Forecast, 2021-2031
4.3.1 The outer membrane vesicles containing membrane proteins (OMVs) and lipopolysaccharide (LPS)
4.3.2 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5 Meningococcal Vaccines Market by End User Forecast, 2021-2031
5.1 Pediatric Segment Market Forecast, 2021-2031
5.1.1 Largest Revenue Grossing Segment
5.1.2 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.2 Adult Segment Market Forecast, 2021-2031
5.2.1 Adult population, between age group 18 to 58, is prone to developing respiratory diseases
5.2.2 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.3 Travellers Segment Market Forecast, 2021-2031
5.3.1 Travellers visiting areas with high endemic needs vaccination with a limit of 5 years prior to next travel
5.3.2 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6 Meningococcal Vaccines Market by Vaccine Brand Forecast, 2021-2031
6.1 Bexsero Segment Market Forecast, 2021-2031
6.1.1 Bexsero- multicomponent meningococcal group B recombinant adsorbed vaccine
6.1.2 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.2 Menactra Segment Market Forecast, 2021-2031
6.2.1 Menactra vaccine protects against infection by one of the most common types of meningococcal bacteria
6.2.2 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.3 Menveo Segment Market Forecast, 2021-2031
6.3.1 Menveo Vaccine is advised children, adolescents, and adults to prevent invasive meningococcal disease
6.3.2 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.4 Others Segment Market Forecast, 2021-2031
6.4.1 Vaccine MenAC projected for infants by reducing cost and without the essential for further vaccination visits or injections
6.4.2 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
7 Global Meningococcal Vaccines Market Regional Forecast, 2021-2031
7.1 Global Meningococcal Vaccines Market by Region Forecast 2021-2031
7.2 Global Meningococcal Vaccines Market Forecast by Region: Recovery Scenarios (V, U, W, L)
8 North America Meningococcal Vaccines Market, 2021-2031
8.1 Largest Market Share acquired by North America in Global Meningococcal Vaccines Market
8.2 North America Meningococcal Vaccines Market by Country, Forecast 2021-2031
8.3 North America Meningococcal Vaccines Market Forecast by Vaccine Type
8.3.1 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
8.4 North America Meningococcal Vaccines Market Forecast by End User
8.4.1 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
8.5 North America Meningococcal Vaccines Market Forecast by Vaccine Brand
8.5.1 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031: Recovery Scenarios (V, U, W, L)
8.6 U.S. Meningococcal Vaccines Market Forecast, 2021-2031
8.6.1 Growing awareness and support from various organizations
8.6.2 Presence of Highly Developed Healthcare Infrastructure
8.6.3 U.S. Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
8.7 Canada Meningococcal Vaccines Market Forecast, 2021-2031
8.7.1 Benefits of manufacturing and R&D Operations in Canada
8.7.2 Canada Government and GSK Supporting for Meningitis Vaccination
8.7.3 Canada Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9 Europe Meningococcal Vaccines Market, 2021-2031
9.1 Favourable Government Support
9.2 Europe Meningococcal Vaccines Market by Country, Forecast 2021-2031
9.3 Europe Meningococcal Vaccines Market Forecast by Vaccine Type
9.3.1 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
9.4 Europe Meningococcal Vaccines Market Forecast by End User
9.4.1 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
9.5 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand
9.6 Germany Meningococcal Vaccines Market Forecast, 2021-2031
9.6.1 Strong Research and Development with new vaccines in pipeline
9.6.2 Meningococcal B vaccination has not yet been introduced in the vaccination schedule in Germany
9.6.3 Germany Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.7 U.K. Meningococcal Vaccines Market Forecast, 2021-2031
9.7.1 Growing ageing population creating challenges
9.7.2 Growing awareness campaigns among population
9.7.3 U.K. Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.8 France Meningococcal Vaccines Market Forecast, 2021-2031
9.8.1 Affordable Healthcare Services with Workforce Flexibility
9.8.2 France government vaccination programme and low uptake of Meningococcal C Vaccine in France
9.8.3 France Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.9 Italy Meningococcal Vaccines Market Forecast, 2021
9.9.1 Italy Vaccination programme
9.9.2 Italy –Growing geriatric population coupled with increase in no of cases of Invasive Meningococcal Disease (IMD)
9.9.3 Italy Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.10 Spain Meningococcal Vaccines Market Forecast, 2021-2031
9.10.1 Experience in A Limited Release of the Vaccine for Private Market Use in Spain
9.10.2 Rise in the incidence rate of IMD in Adults
9.10.3 Spain Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.11 Russia Meningococcal Vaccines Market Forecast, 2021-2031
9.11.1 Promising Russian Pharmaceutical Industry
9.11.2 Promising partnership by Sanofi and Nanolek against Meningococcal infection
9.11.3 Russia Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.12 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031
9.12.1 Growing prevalence of bacterial infections and strategic initiatives by major market players
9.12.2 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10 Asia Pacific Meningococcal Vaccines Market, 2021-2031
10.1 Increased funding for vaccines and immunization in developing countries
10.2 Invasive respiratory tract infections, and smoking and overcrowded living conditions and specific adolescent social behaviour are risk factors in developing countries
10.3 Asia Pacific Meningococcal Vaccines Market by Country, Forecast 2021-2031
10.4 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type
10.4.1 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
10.5 Asia Pacific Meningococcal Vaccines Market Forecast by End User
10.5.1 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
10.6 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand
10.7 Japan Meningococcal Vaccines Market Forecast, 2021-2031
10.7.1 Japan Accounted for the Largest Market Share in the Asia Pacific region
10.7.2 Meningitis and the Olympics: Japan 2020
10.7.3 Japan Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.8 China Meningococcal Vaccines Market Forecast, 2021-2031
10.8.1 Growing Government initiatives to boost the market demand
10.8.2 Increasing Healthcare Spending Propels the Market Growth
10.8.3 China Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.9 India Meningococcal Vaccines Market Forecast, 2021-2031
10.9.1 Meningococcal disease burden data remain unreliable
10.9.2 Developing Healthcare Infrastructure
10.9.3 India Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.10 Australia Meningococcal Vaccines Market Forecast, 2021-2031
10.10.1 Australia is one of the major country to include Meningococcal ACWY vaccine through NIP
10.10.2 Government initiatives and spread of meningococcal disease in Australia
10.10.3 Australia Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.11 South Korea Meningococcal Vaccines Market Forecast, 2021-2031
10.11.1 Spreading HIV in South Korea Region
10.11.2 IMD in South Korea Region
10.11.3 South Korea Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.12 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031
10.12.1 Burden of meningococcal disease is high among children throughout the Asia Pacific region
10.12.2 Risk and burden of IMD across the Asia Pacific region is relatively low
10.12.3 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11 Latin America Meningococcal Vaccines Market, 2021-2031
11.1 Unavailability of data has contributed to uncertain policy decisions
11.2 Need to improve surveillance in Latin America region
11.3 Latin America Meningococcal Vaccines Market by Country, Forecast 2021-2031
11.4 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type
11.4.1 Latin America Meningococcal Vaccines Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
11.5 Latin America Meningococcal Vaccines Market Forecast by End User
11.5.1 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
11.6 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand
11.7 Brazil Meningococcal Vaccines Market Forecast, 2021-2031
11.7.1 Country with highest documented levels of Invasive Meningococcal Disease
11.7.2 Prevalence of Meningococcal disease due to other serogroups which continues to be major concern
11.7.3 Brazil Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11.8 Mexico Meningococcal Vaccines Market Forecast, 2021-2031
11.8.1 Mexico- Attractive market to capitalize in the Pharmaceutical Industry
11.8.2 Mexico- Meningococcal meningitis is reported as a rare condition
11.8.3 Recovery Scenarios (V, U, W, L): Mexico Meningococcal Vaccines Market Forecast, 2021-2031
11.9 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031
11.9.1 Evolving Healthcare Infrastructure
11.9.2 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12 Middle East and Asia Meningococcal Vaccines Market, 2021-2031
12.1 Middle East and Africa Meningococcal Vaccines Market by Country, Forecast 2021-2031
12.2 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type
12.2.1 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
12.3 Middle East and Africa Meningococcal Vaccines Market Forecast by End User
12.3.1 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
12.4 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Brand
12.5 South Africa Meningococcal Vaccines Market Forecast, 2021-2031
12.5.1 African meningitis belt – Region with highest burden of disease
12.5.2 Growing GDP and Substantial progress in the management of infectious diseases
12.5.3 South Africa Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12.6 GCC Meningococcal Vaccines Market Forecast, 2021-2031
12.6.1 Government funding and immunization is not major constraint in this region
12.6.2 UNICEF and partners could promote active sharing of information topics among MENA Countries
12.6.3 GCC Meningococcal Vaccines Market Forecast 2021-2031: Recovery Scenarios (V, U, W, L):
12.7 Rest of Middle East and Asia Meningococcal Vaccines Market Forecast, 2021-2031
12.7.1 Developing Pharmaceutical Industry along with government support
12.7.2 Under developed countries in the region supported by GAVI along with government support
12.7.3 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
13 Company Profiles
13.1 Company Share Analysis
13.2 Meningococcal vaccine market Recent Developments 2018-2020
13.1 Sanofi
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2016-2020
13.1.3.2 Regional Revenue Shares, 2020
13.1.3.3 Product Revenue Shares, 2020
13.1.4 Product Benchmarking
13.1.5 Recent Developments, 2017-2021
13.2 Merck & Co., Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2015-2019 or 2016-2021
13.2.3.2 Regional Revenue Shares, 2020
13.2.3.3 Product Revenue Shares, 2020
13.2.4 Product Benchmarking
13.3 GlaxoSmithKline plc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2016-2020
13.3.3.2 Regional Revenue Shares, 2020
13.3.3.3 Product Revenue Shares, 2020
13.3.4 Product Benchmarking
13.3.5 Recent Developments, 2017-2021
13.4 Pfizer Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2016-2020
13.4.3.2 Regional Revenue Shares, 2020
13.4.3.3 Product Revenue Shares, 2020
13.4.4 Product Benchmarking
13.4.5 Recent Developments, 2017-2021
13.5 Serum Institute of India Pvt. Ltd.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 Zhi Fei Biological
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.7 Hualan Biological Engineering Inc
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.7.4 Recent Developments, 2017-2021
13.8 Incepta Pharmaceuticals Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 Walvax Biotechnology Co., Ltd.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 BIO-MED
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.11 JN International Medical Corporation
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
14.3 Global Meningococcal Vaccines Market Share Forecast by Region
List of Tables
Table 1 Global Meningococcal Vaccines Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 14 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 19 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 20 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 36 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 41 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Meningococcal Vaccines Market for Manactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 46 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 51 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, 6CAGR %)
Table 56 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 60 North America Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 62 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 63 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 64 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 65 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 66 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 67 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 68 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 69 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 70 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 71 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 72 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 73 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 74 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 75 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 76 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 77 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 82 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 Europe Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 87 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 88 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 89 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 90 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 91 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 92 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 93 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 94 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 95 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 96 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 97 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 98 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 99 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 100 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 101 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 102 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 103 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 104 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 105 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 106 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 107 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 108 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 109 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 110 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 111 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 112 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 113 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 114 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 115 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 116 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 117 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 118 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 119 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 120 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 121 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 122 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 123 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 124 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 125 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 126 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 127 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 128 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 129 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 130 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 131 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 132 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 133 Overview of the epidemiology and prevention of IMD across the Asia–Pacific region:
Table 134 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 135 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 136 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 141 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 142 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 143 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 144 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 145 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 146 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 147 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 148 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 149 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 150 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 151 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 152 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 153 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 154 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 155 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 156 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 157 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 162 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 163 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 164 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 165 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 166 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 167 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 172 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 Latin America Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 177 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 178 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 179 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 180 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 181 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 182 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 184 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 185 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 186 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 187 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 188 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 189 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 194 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 199 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 200 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 201 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 202 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 203 Middle East and Africa Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 204 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 205 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 210 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 215 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 216 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 217 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 218 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 219 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 220 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 221 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 222 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 223 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 224 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 225 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 227 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 228 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 229 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 230 Meningococcal Vaccine Market Recent Developments, 2017-2021
Table 231 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 232 Sanofi: Product Benchmarking
Table 233 Sanofi: Recent Developments, 2017-2021
Table 234 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 235 Merck & Co., Inc.: Product Benchmarking
Table 236 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 237 GlaxiSmithKline plc.: Product Benchmarking
Table 238 GlaxoSmithkline plc.: Recent Developments, 2017-2021
Table 239 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 240 Pfizer Inc.: Product Benchmarking
Table 241 Pfizer Inc.: Recent Developments, 2017-2021
Table 242 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 243 Serum Institute of India Pvt. Ltd.: Product Benchmarking
Table 244 Zhi Fei Biological: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Zhi Fei Biological : Product Benchmarking
Table 246 Hualan biological Engineering Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 247 Hualan Biological Engineering inc. : Product Benchmarking
Table 248 Hualan Biological Engineering Inc.: Recent Developments, 2017-2021
Table 249 Incepta Pharmaceuticals Ltd. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 250 Incepta Pharmaceuticals Ltd. : Product Benchmarking
Table 251 Walvwax Biotechnology Co., Ltd. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 252 CompanyA: Product Benchmarking
Table 253 BIO-MED : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 254 BIO-MED : Product Benchmarking
Table 255 JN International Medical Corporation : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 256 JN International Medical Corporation : Product Benchmarking
List of Figures
Figure 1 Global Meningococcal Vaccines Market Size Forecast 2021-2031 (US$Mn, AGR %)
Figure 2 Global Meningococcal Vaccines Market Segmentation
Figure 3 Global Meningococcal Vaccines Market: Market Trends
Figure 4 Global Meningococcal Vaccines Market: Porter’s Five Forces Analysis
Figure 5 Global Meningococcal Vaccines Market: PEST Analysis
Figure 6 Global Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR %)
Figure 7 Global Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2021, 2026, 2031 (%)
Figure 8 Global Meningococcal Vaccines Market for Conjugate Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Global Meningococcal Vaccines Market for Polysaccharide Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Global Meningococcal Vaccines Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR %)
Figure 19 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 20 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 21 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 22 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 23 Global Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR %)
Figure 24 Global Meningococcal Vaccines Market Share Forecast by End User, 2021, 2026, 2031 (%)
Figure 25 Global Meningococcal Vaccines Market for Pediatric Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 26 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 27 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 28 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 29 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 30 Global Meningococcal Vaccines Market for Adult Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 31 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 32 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 33 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 34 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 35 Global Meningococcal Vaccines Market for Travellers Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 36 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 37 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 38 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 39 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 40 Global Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR %)
Figure 41 Global Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2021, 2026, 2031 (%)
Figure 42 Global Meningococcal Vaccines Market for Bexsero Segment: Revenue Forecast 2021-2031 (US$ million, AGR %)
Figure 43 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 44 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 45 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 46 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 47 Global Meningococcal Vaccines Market for Menactra Segment: Revenue Forecast 2021-2031 (US$ million, AGR %)
Figure 48 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 49 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 50 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 51 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 52 Global Meningococcal Vaccines Market for Menveo Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 53 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 54 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 55 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 56 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 57 Global Meningococcal Vaccines Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 58 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 59 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 60 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 61 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 62 Global Meningococcal Vaccines Market Forecast by Region 2021-2031 (US$ million)
Figure 63 Global Meningococcal Vaccines Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 64 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 65 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 66 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 67 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 68 North America Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 69 North America Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 70 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%)
Figure 71 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 76 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 81 North America Meningococcal Vaccines Market Forecast by Vaccine Brand , 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 86 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 87 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 88 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 89 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 90 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 91 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 92 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 93 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 94 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 95 Europe Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 96 Europe Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 97 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%)
Figure 98 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 99 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 100 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 101 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 102 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 103 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 104 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovey
Figure 105 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 106 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 107 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 108 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 109 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 110 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 111 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 112 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 113 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 114 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 115 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 116 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 117 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 118 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 119 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 120 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 121 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 122 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 123 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 124 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 125 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 126 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 127 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 128 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 129 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 130 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 131 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 132 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 133 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 134 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 135 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 136 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 137 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 138 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 139 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 140 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 141 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 142 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 143 Asia Pacific Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 144 Asia Pacific Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 145 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%)
Figure 146 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 147 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 148 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 149 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 150 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 151 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 152 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 153 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 154 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 155 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 156 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 157 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 158 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 159 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 160 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 161 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 162 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 163 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 164 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 165 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 166 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 167 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 168 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 169 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 170 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 171 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 172 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 173 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 174 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 175 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 176 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 177 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 178 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 179 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 180 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 181 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 182 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 183 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 184 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 185 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 186 Latin America Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 187 Latin America Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 188 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR %)
Figure 189 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 190 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 191 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 192 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 193 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR %)
Figure 194 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 195 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 196 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 197 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 198 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 199 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 200 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 201 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 202 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 203 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 204 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 205 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 206 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 207 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 208 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 209 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 210 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 211 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 212 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 213 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 214 Middle East and Africa Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 215 Middle East and Africa Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 216 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR %)
Figure 217 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 218 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 219 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 220 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 221 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 222 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 223 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 224 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 225 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 226 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 227 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 228 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 229 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 230 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 231 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 232 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 233 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 234 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 235 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 236 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 237 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 238 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 239 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 240 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 241 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 242 Global Company Share Analysis 2020
Figure 243 Sanofi: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 244 Sanofi: Regional Revenue Shares, 2020
Figure 245 Sanofi: Product Revenue Shares, 2020
Figure 246 Merck & Co., Inc.: Net Revenue, 2015-2020 (US$ billion, AGR%)
Figure 247 Merck & Co., Inc.: Regional Revenue Shares, 2020
Figure 248 Merck & Co., Inc.: Product Revenue Shares, 2020
Figure 249 GlaxoSmithKline plc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 250 GlaxoSmithKline plc.: Regional Revenue Shares, 2020
Figure 251 GlaxoSmithKline plc.: Product Revenue Shares, 2020
Figure 252 Pfizer Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 253 Pfizer Inc. : Regional Revenue Shares, 2020
Figure 254 Pfizer Inc. : Product Revenue Shares, 2020
Figure 255 Global Meningococcal Vaccines Market Share Forecast by Region 2021, 2026, 2031 (%)
1.1 Introduction to Meningococcal Vaccines Market
1.2 Meningococcal Vaccines Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers
3.1.1 Increasing prevalence of meningitis
3.1.2 Increasing initiatives by government and regulatory authorities
3.1.3 Presence of Non-profit Organizations Providing funds for research projects
3.1.4 Vaccine trials and are expected to commercialized during the forecast period
3.2 Restraints
3.2.1 Low Production rate and high cost
3.2.2 High Costs of Drug Development Limits the Entry of New Players
3.2.3 Long Vaccine Manufacturing Timelines to Impede the Growth of the Vaccines Market
3.3 Opportunities
3.3.1 Increasing Inclusion in NIPs Unlocking New Windows of Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier: Moderate
3.4.2 Bargaining Power of Buyer: Moderate
3.4.3 Competitive Rivalry: High
3.4.4 Threat of New Entrants: low
3.4.5 Threat of Substitutes: Low
3.5 PEST Analysis
3.5.1 Political Factors Impacting Meningococcal Vaccines Market
3.5.2 Economic Factors Impacting Meningococcal Vaccines Market
3.5.3 Social Factors Impacting Meningococcal Vaccines Market
3.5.4 Technological Factors Impacting Meningococcal Vaccines Market
4 Meningococcal Vaccines Market by Vaccine Type Forecast, 2021-2031
4.1 Conjugate Segment Market Forecast, 2021-2031
4.1.1 Increasing investment of Government and Private sectors in the development of conjugate Vaccines
4.1.2 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.2 Polysaccharide Segment Market Forecast, 2021-2031
4.2.1 Polysaccharide Vaccines is expected to hold Largest Market Share over the forecast period
4.2.2 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
4.3 Other Segment Market Forecast, 2021-2031
4.3.1 The outer membrane vesicles containing membrane proteins (OMVs) and lipopolysaccharide (LPS)
4.3.2 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5 Meningococcal Vaccines Market by End User Forecast, 2021-2031
5.1 Pediatric Segment Market Forecast, 2021-2031
5.1.1 Largest Revenue Grossing Segment
5.1.2 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.2 Adult Segment Market Forecast, 2021-2031
5.2.1 Adult population, between age group 18 to 58, is prone to developing respiratory diseases
5.2.2 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
5.3 Travellers Segment Market Forecast, 2021-2031
5.3.1 Travellers visiting areas with high endemic needs vaccination with a limit of 5 years prior to next travel
5.3.2 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6 Meningococcal Vaccines Market by Vaccine Brand Forecast, 2021-2031
6.1 Bexsero Segment Market Forecast, 2021-2031
6.1.1 Bexsero- multicomponent meningococcal group B recombinant adsorbed vaccine
6.1.2 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.2 Menactra Segment Market Forecast, 2021-2031
6.2.1 Menactra vaccine protects against infection by one of the most common types of meningococcal bacteria
6.2.2 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.3 Menveo Segment Market Forecast, 2021-2031
6.3.1 Menveo Vaccine is advised children, adolescents, and adults to prevent invasive meningococcal disease
6.3.2 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
6.4 Others Segment Market Forecast, 2021-2031
6.4.1 Vaccine MenAC projected for infants by reducing cost and without the essential for further vaccination visits or injections
6.4.2 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
7 Global Meningococcal Vaccines Market Regional Forecast, 2021-2031
7.1 Global Meningococcal Vaccines Market by Region Forecast 2021-2031
7.2 Global Meningococcal Vaccines Market Forecast by Region: Recovery Scenarios (V, U, W, L)
8 North America Meningococcal Vaccines Market, 2021-2031
8.1 Largest Market Share acquired by North America in Global Meningococcal Vaccines Market
8.2 North America Meningococcal Vaccines Market by Country, Forecast 2021-2031
8.3 North America Meningococcal Vaccines Market Forecast by Vaccine Type
8.3.1 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
8.4 North America Meningococcal Vaccines Market Forecast by End User
8.4.1 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
8.5 North America Meningococcal Vaccines Market Forecast by Vaccine Brand
8.5.1 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031: Recovery Scenarios (V, U, W, L)
8.6 U.S. Meningococcal Vaccines Market Forecast, 2021-2031
8.6.1 Growing awareness and support from various organizations
8.6.2 Presence of Highly Developed Healthcare Infrastructure
8.6.3 U.S. Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
8.7 Canada Meningococcal Vaccines Market Forecast, 2021-2031
8.7.1 Benefits of manufacturing and R&D Operations in Canada
8.7.2 Canada Government and GSK Supporting for Meningitis Vaccination
8.7.3 Canada Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9 Europe Meningococcal Vaccines Market, 2021-2031
9.1 Favourable Government Support
9.2 Europe Meningococcal Vaccines Market by Country, Forecast 2021-2031
9.3 Europe Meningococcal Vaccines Market Forecast by Vaccine Type
9.3.1 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
9.4 Europe Meningococcal Vaccines Market Forecast by End User
9.4.1 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
9.5 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand
9.6 Germany Meningococcal Vaccines Market Forecast, 2021-2031
9.6.1 Strong Research and Development with new vaccines in pipeline
9.6.2 Meningococcal B vaccination has not yet been introduced in the vaccination schedule in Germany
9.6.3 Germany Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.7 U.K. Meningococcal Vaccines Market Forecast, 2021-2031
9.7.1 Growing ageing population creating challenges
9.7.2 Growing awareness campaigns among population
9.7.3 U.K. Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.8 France Meningococcal Vaccines Market Forecast, 2021-2031
9.8.1 Affordable Healthcare Services with Workforce Flexibility
9.8.2 France government vaccination programme and low uptake of Meningococcal C Vaccine in France
9.8.3 France Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.9 Italy Meningococcal Vaccines Market Forecast, 2021
9.9.1 Italy Vaccination programme
9.9.2 Italy –Growing geriatric population coupled with increase in no of cases of Invasive Meningococcal Disease (IMD)
9.9.3 Italy Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.10 Spain Meningococcal Vaccines Market Forecast, 2021-2031
9.10.1 Experience in A Limited Release of the Vaccine for Private Market Use in Spain
9.10.2 Rise in the incidence rate of IMD in Adults
9.10.3 Spain Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.11 Russia Meningococcal Vaccines Market Forecast, 2021-2031
9.11.1 Promising Russian Pharmaceutical Industry
9.11.2 Promising partnership by Sanofi and Nanolek against Meningococcal infection
9.11.3 Russia Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
9.12 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031
9.12.1 Growing prevalence of bacterial infections and strategic initiatives by major market players
9.12.2 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10 Asia Pacific Meningococcal Vaccines Market, 2021-2031
10.1 Increased funding for vaccines and immunization in developing countries
10.2 Invasive respiratory tract infections, and smoking and overcrowded living conditions and specific adolescent social behaviour are risk factors in developing countries
10.3 Asia Pacific Meningococcal Vaccines Market by Country, Forecast 2021-2031
10.4 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type
10.4.1 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
10.5 Asia Pacific Meningococcal Vaccines Market Forecast by End User
10.5.1 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
10.6 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand
10.7 Japan Meningococcal Vaccines Market Forecast, 2021-2031
10.7.1 Japan Accounted for the Largest Market Share in the Asia Pacific region
10.7.2 Meningitis and the Olympics: Japan 2020
10.7.3 Japan Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.8 China Meningococcal Vaccines Market Forecast, 2021-2031
10.8.1 Growing Government initiatives to boost the market demand
10.8.2 Increasing Healthcare Spending Propels the Market Growth
10.8.3 China Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.9 India Meningococcal Vaccines Market Forecast, 2021-2031
10.9.1 Meningococcal disease burden data remain unreliable
10.9.2 Developing Healthcare Infrastructure
10.9.3 India Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.10 Australia Meningococcal Vaccines Market Forecast, 2021-2031
10.10.1 Australia is one of the major country to include Meningococcal ACWY vaccine through NIP
10.10.2 Government initiatives and spread of meningococcal disease in Australia
10.10.3 Australia Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.11 South Korea Meningococcal Vaccines Market Forecast, 2021-2031
10.11.1 Spreading HIV in South Korea Region
10.11.2 IMD in South Korea Region
10.11.3 South Korea Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
10.12 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031
10.12.1 Burden of meningococcal disease is high among children throughout the Asia Pacific region
10.12.2 Risk and burden of IMD across the Asia Pacific region is relatively low
10.12.3 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11 Latin America Meningococcal Vaccines Market, 2021-2031
11.1 Unavailability of data has contributed to uncertain policy decisions
11.2 Need to improve surveillance in Latin America region
11.3 Latin America Meningococcal Vaccines Market by Country, Forecast 2021-2031
11.4 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type
11.4.1 Latin America Meningococcal Vaccines Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
11.5 Latin America Meningococcal Vaccines Market Forecast by End User
11.5.1 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
11.6 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand
11.7 Brazil Meningococcal Vaccines Market Forecast, 2021-2031
11.7.1 Country with highest documented levels of Invasive Meningococcal Disease
11.7.2 Prevalence of Meningococcal disease due to other serogroups which continues to be major concern
11.7.3 Brazil Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
11.8 Mexico Meningococcal Vaccines Market Forecast, 2021-2031
11.8.1 Mexico- Attractive market to capitalize in the Pharmaceutical Industry
11.8.2 Mexico- Meningococcal meningitis is reported as a rare condition
11.8.3 Recovery Scenarios (V, U, W, L): Mexico Meningococcal Vaccines Market Forecast, 2021-2031
11.9 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031
11.9.1 Evolving Healthcare Infrastructure
11.9.2 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12 Middle East and Asia Meningococcal Vaccines Market, 2021-2031
12.1 Middle East and Africa Meningococcal Vaccines Market by Country, Forecast 2021-2031
12.2 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type
12.2.1 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031: Recovery Scenarios (V, U, W, L)
12.3 Middle East and Africa Meningococcal Vaccines Market Forecast by End User
12.3.1 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
12.4 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Brand
12.5 South Africa Meningococcal Vaccines Market Forecast, 2021-2031
12.5.1 African meningitis belt – Region with highest burden of disease
12.5.2 Growing GDP and Substantial progress in the management of infectious diseases
12.5.3 South Africa Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12.6 GCC Meningococcal Vaccines Market Forecast, 2021-2031
12.6.1 Government funding and immunization is not major constraint in this region
12.6.2 UNICEF and partners could promote active sharing of information topics among MENA Countries
12.6.3 GCC Meningococcal Vaccines Market Forecast 2021-2031: Recovery Scenarios (V, U, W, L):
12.7 Rest of Middle East and Asia Meningococcal Vaccines Market Forecast, 2021-2031
12.7.1 Developing Pharmaceutical Industry along with government support
12.7.2 Under developed countries in the region supported by GAVI along with government support
12.7.3 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
13 Company Profiles
13.1 Company Share Analysis
13.2 Meningococcal vaccine market Recent Developments 2018-2020
13.1 Sanofi
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2016-2020
13.1.3.2 Regional Revenue Shares, 2020
13.1.3.3 Product Revenue Shares, 2020
13.1.4 Product Benchmarking
13.1.5 Recent Developments, 2017-2021
13.2 Merck & Co., Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2015-2019 or 2016-2021
13.2.3.2 Regional Revenue Shares, 2020
13.2.3.3 Product Revenue Shares, 2020
13.2.4 Product Benchmarking
13.3 GlaxoSmithKline plc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2016-2020
13.3.3.2 Regional Revenue Shares, 2020
13.3.3.3 Product Revenue Shares, 2020
13.3.4 Product Benchmarking
13.3.5 Recent Developments, 2017-2021
13.4 Pfizer Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2016-2020
13.4.3.2 Regional Revenue Shares, 2020
13.4.3.3 Product Revenue Shares, 2020
13.4.4 Product Benchmarking
13.4.5 Recent Developments, 2017-2021
13.5 Serum Institute of India Pvt. Ltd.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 Zhi Fei Biological
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.7 Hualan Biological Engineering Inc
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.7.4 Recent Developments, 2017-2021
13.8 Incepta Pharmaceuticals Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 Walvax Biotechnology Co., Ltd.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 BIO-MED
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.11 JN International Medical Corporation
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
14.3 Global Meningococcal Vaccines Market Share Forecast by Region
List of Tables
Table 1 Global Meningococcal Vaccines Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
Table 2 Global Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 3 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 4 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 5 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 6 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 7 Global Meningococcal Vaccines Market for Conjugate Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 8 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 9 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 10 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 11 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 12 Global Meningococcal Vaccines Market for Polysaccharide Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 13 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 14 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 15 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 16 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 17 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 18 Global Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 19 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 20 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Meningococcal Vaccines Market for Pediatric Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 25 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Meningococcal Vaccines Market for Adult Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 30 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 31 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 32 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 33 Global Meningococcal Vaccines Market for Travellers Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 34 Global Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 35 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 36 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Meningococcal Vaccines Market for Bexsero Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 41 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Meningococcal Vaccines Market for Manactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Meningococcal Vaccines Market for Menactra Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 46 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Meningococcal Vaccines Market for Menveo Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 51 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Meningococcal Vaccines Market for Others Segment Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, 6CAGR %)
Table 56 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 57 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 58 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 59 Global Meningococcal Vaccines Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 60 North America Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 61 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 62 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 63 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 64 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 65 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 66 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 67 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 68 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 69 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 70 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 71 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 72 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 73 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 74 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 75 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 76 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 77 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 82 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 Europe Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 87 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 88 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 89 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 90 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 91 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 92 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 93 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 94 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 95 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 96 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 97 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 98 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 99 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 100 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 101 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 102 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 103 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 104 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 105 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 106 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 107 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 108 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 109 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 110 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 111 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 112 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 113 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 114 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 115 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 116 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 117 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 118 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 119 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 120 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 121 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 122 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 123 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 124 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 125 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 126 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 127 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 128 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 129 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 130 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 131 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 132 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 133 Overview of the epidemiology and prevention of IMD across the Asia–Pacific region:
Table 134 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 135 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 136 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 137 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 138 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 139 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 140 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 141 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 142 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 143 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 144 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 145 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 146 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 147 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 148 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 149 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 150 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 151 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 152 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 153 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 154 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 155 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 156 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 157 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 158 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 159 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 160 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 161 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 162 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 163 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 164 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 165 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 166 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 167 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 168 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 169 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 170 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 171 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 172 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 173 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 174 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 175 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 176 Latin America Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 177 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 178 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 179 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 180 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 181 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 182 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 183 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 184 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 185 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 186 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 187 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 188 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 189 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 194 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 199 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 200 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 201 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 202 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 203 Middle East and Africa Meningococcal Vaccines Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 204 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 205 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR %)
Table 210 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 215 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 216 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 217 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 218 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 219 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 220 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 221 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 222 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 223 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 224 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 225 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
Table 226 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 227 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 228 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 229 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 230 Meningococcal Vaccine Market Recent Developments, 2017-2021
Table 231 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 232 Sanofi: Product Benchmarking
Table 233 Sanofi: Recent Developments, 2017-2021
Table 234 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 235 Merck & Co., Inc.: Product Benchmarking
Table 236 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 237 GlaxiSmithKline plc.: Product Benchmarking
Table 238 GlaxoSmithkline plc.: Recent Developments, 2017-2021
Table 239 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 240 Pfizer Inc.: Product Benchmarking
Table 241 Pfizer Inc.: Recent Developments, 2017-2021
Table 242 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 243 Serum Institute of India Pvt. Ltd.: Product Benchmarking
Table 244 Zhi Fei Biological: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Zhi Fei Biological : Product Benchmarking
Table 246 Hualan biological Engineering Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 247 Hualan Biological Engineering inc. : Product Benchmarking
Table 248 Hualan Biological Engineering Inc.: Recent Developments, 2017-2021
Table 249 Incepta Pharmaceuticals Ltd. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 250 Incepta Pharmaceuticals Ltd. : Product Benchmarking
Table 251 Walvwax Biotechnology Co., Ltd. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 252 CompanyA: Product Benchmarking
Table 253 BIO-MED : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 254 BIO-MED : Product Benchmarking
Table 255 JN International Medical Corporation : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 256 JN International Medical Corporation : Product Benchmarking
List of Figures
Figure 1 Global Meningococcal Vaccines Market Size Forecast 2021-2031 (US$Mn, AGR %)
Figure 2 Global Meningococcal Vaccines Market Segmentation
Figure 3 Global Meningococcal Vaccines Market: Market Trends
Figure 4 Global Meningococcal Vaccines Market: Porter’s Five Forces Analysis
Figure 5 Global Meningococcal Vaccines Market: PEST Analysis
Figure 6 Global Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR %)
Figure 7 Global Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2021, 2026, 2031 (%)
Figure 8 Global Meningococcal Vaccines Market for Conjugate Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 9 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 10 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 11 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 12 Global Meningococcal Vaccines Market for Conjugate Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 13 Global Meningococcal Vaccines Market for Polysaccharide Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 14 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 15 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 16 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 17 Global Meningococcal Vaccines Market for Polysaccharide Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 18 Global Meningococcal Vaccines Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR %)
Figure 19 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 20 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 21 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 22 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 23 Global Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR %)
Figure 24 Global Meningococcal Vaccines Market Share Forecast by End User, 2021, 2026, 2031 (%)
Figure 25 Global Meningococcal Vaccines Market for Pediatric Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 26 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 27 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 28 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 29 Global Meningococcal Vaccines Market for Pediatric Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 30 Global Meningococcal Vaccines Market for Adult Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 31 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 32 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 33 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 34 Global Meningococcal Vaccines Market for Adult Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 35 Global Meningococcal Vaccines Market for Travellers Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 36 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 37 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 38 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 39 Global Meningococcal Vaccines Market for Travellers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 40 Global Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR %)
Figure 41 Global Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2021, 2026, 2031 (%)
Figure 42 Global Meningococcal Vaccines Market for Bexsero Segment: Revenue Forecast 2021-2031 (US$ million, AGR %)
Figure 43 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 44 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 45 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 46 Global Meningococcal Vaccines Market for Bexsero Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 47 Global Meningococcal Vaccines Market for Menactra Segment: Revenue Forecast 2021-2031 (US$ million, AGR %)
Figure 48 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 49 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 50 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 51 Global Meningococcal Vaccines Market for Menactra Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 52 Global Meningococcal Vaccines Market for Menveo Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 53 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 54 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 55 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 56 Global Meningococcal Vaccines Market for Menveo Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 57 Global Meningococcal Vaccines Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
Figure 58 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 59 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 60 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 61 Global Meningococcal Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 62 Global Meningococcal Vaccines Market Forecast by Region 2021-2031 (US$ million)
Figure 63 Global Meningococcal Vaccines Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 64 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 65 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 66 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 67 Global Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 68 North America Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 69 North America Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 70 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%)
Figure 71 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 72 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 73 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 74 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 75 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 76 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 77 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 78 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 79 North America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 80 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 81 North America Meningococcal Vaccines Market Forecast by Vaccine Brand , 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 82 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 83 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 84 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 85 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 86 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 87 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 88 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 89 U.S. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 90 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 91 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 92 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 93 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 94 Canada Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 95 Europe Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 96 Europe Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 97 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%)
Figure 98 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 99 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 100 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 101 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 102 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 103 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 104 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovey
Figure 105 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 106 Europe Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 107 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 108 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 109 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 110 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 111 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 112 Germany Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 113 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 114 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 115 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 116 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 117 U.K. Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 118 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 119 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 120 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 121 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 122 France Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 123 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 124 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 125 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 126 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 127 Italy Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 128 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 129 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 130 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 131 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 132 Spain Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 133 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 134 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 135 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 136 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 137 Russia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 138 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 139 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 140 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 141 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 142 Rest of Europe Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 143 Asia Pacific Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 144 Asia Pacific Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 145 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%)
Figure 146 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 147 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 148 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 149 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 150 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 151 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 152 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 153 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 154 Asia Pacific Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 155 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 156 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 157 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 158 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 159 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 160 Japan Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 161 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 162 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 163 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 164 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 165 China Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 166 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 167 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 168 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 169 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 170 India Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 171 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 172 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 173 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 174 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 175 Australia Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 176 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 177 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 178 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 179 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 180 South Korea Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 181 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 182 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 183 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 184 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 185 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 186 Latin America Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 187 Latin America Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 188 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR %)
Figure 189 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 190 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 191 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 192 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 193 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR %)
Figure 194 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 195 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 196 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 197 Latin America Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 198 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 199 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 200 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 201 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 202 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 203 Brazil Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 204 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 205 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 206 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 207 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 208 Mexico Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 209 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 210 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 211 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 212 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 213 Rest of Latin America Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 214 Middle East and Africa Meningococcal Vaccines Market Forecast by Country 2021-2031 (US$ million)
Figure 215 Middle East and Africa Meningococcal Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
Figure 216 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR %)
Figure 217 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 218 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 219 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 220 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Type, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 221 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%)
Figure 222 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 223 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 224 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 225 Middle East and Africa Meningococcal Vaccines Market Forecast by End User, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 226 Middle East and Africa Meningococcal Vaccines Market Forecast by Vaccine Brand, 2021-2031 (US$ million, AGR%)
Figure 227 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 228 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 229 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 230 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 231 South Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 232 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 233 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 234 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 235 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 236 GCC Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 237 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
Figure 238 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery
Figure 239 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery
Figure 240 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery
Figure 241 Rest of Middle East and Africa Meningococcal Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery
Figure 242 Global Company Share Analysis 2020
Figure 243 Sanofi: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 244 Sanofi: Regional Revenue Shares, 2020
Figure 245 Sanofi: Product Revenue Shares, 2020
Figure 246 Merck & Co., Inc.: Net Revenue, 2015-2020 (US$ billion, AGR%)
Figure 247 Merck & Co., Inc.: Regional Revenue Shares, 2020
Figure 248 Merck & Co., Inc.: Product Revenue Shares, 2020
Figure 249 GlaxoSmithKline plc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 250 GlaxoSmithKline plc.: Regional Revenue Shares, 2020
Figure 251 GlaxoSmithKline plc.: Product Revenue Shares, 2020
Figure 252 Pfizer Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 253 Pfizer Inc. : Regional Revenue Shares, 2020
Figure 254 Pfizer Inc. : Product Revenue Shares, 2020
Figure 255 Global Meningococcal Vaccines Market Share Forecast by Region 2021, 2026, 2031 (%)
Companies Profiled in the Report:
BIO-MED
GlaxoSmithKline plc.
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Ltd.
JN International Medical Corporation
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Serum Institute of India Pvt. Ltd.
Walvax Biotechnology Co.Ltd.
Zhi Fei Biological
List of Companies Mentioned in the Report:
Abbott Laboratories
AbbVie
Allergan
AstraZeneca AB,
Aurobindo Pharma
Boehringer Ingelheim Corporation
Bristol-Myers-Squibb,
Cipla
F. Hoffmann-La Roche Ltd
Gilead Sciences
GlaxoSmithKline (GSK)
Johnson & Johnson
Merck & Co
Novartis
Pfizer
SHIONOGI Co., Ltd.
List of Organizations Mentioned in the Report:
Centers for Disease Control and Prevention (CDC)
Central Drug Standard Control Organization (CDSCO)
Centre for Pharmaceutical Administration Health Sciences Authority
European Medicines Agency (EMA)
European Union
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare(MHLW)
National Institute of Health (NIH)
NCBI
Organisation for Economic Co-operation and Development (OECD)
Pharmaceuticals and Medical Devices Agency (PMDA)
Statistical Office of the European Union (EUROSTAT)
United Nations (UN)
United Nations Statistics Division (UNSD)
World Health Organization (WHO)
BIO-MED
GlaxoSmithKline plc.
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Ltd.
JN International Medical Corporation
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Serum Institute of India Pvt. Ltd.
Walvax Biotechnology Co.Ltd.
Zhi Fei Biological
List of Companies Mentioned in the Report:
Abbott Laboratories
AbbVie
Allergan
AstraZeneca AB,
Aurobindo Pharma
Boehringer Ingelheim Corporation
Bristol-Myers-Squibb,
Cipla
F. Hoffmann-La Roche Ltd
Gilead Sciences
GlaxoSmithKline (GSK)
Johnson & Johnson
Merck & Co
Novartis
Pfizer
SHIONOGI Co., Ltd.
List of Organizations Mentioned in the Report:
Centers for Disease Control and Prevention (CDC)
Central Drug Standard Control Organization (CDSCO)
Centre for Pharmaceutical Administration Health Sciences Authority
European Medicines Agency (EMA)
European Union
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare(MHLW)
National Institute of Health (NIH)
NCBI
Organisation for Economic Co-operation and Development (OECD)
Pharmaceuticals and Medical Devices Agency (PMDA)
Statistical Office of the European Union (EUROSTAT)
United Nations (UN)
United Nations Statistics Division (UNSD)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Meningococcal Vaccines Market Report 2021-2031Related reports
Vaccine Contract Manufacturing Market Forecast 2020-2030
The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of...
Full DetailsPublished: 08 April 2020Vaccines Sales Market Report 2020-2030
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New...
Full DetailsPublished: 10 September 2020Vaccine Delivery Devices Market Report 2021-2031
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product...Full DetailsPublished: 06 January 2021Anti-infective Vaccines Market Report 2021-2031
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that...Full DetailsPublished: 01 June 2021mRNA Vaccines Market Report 2021-2031
The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative...Full DetailsPublished: 01 October 2020Inactivated Vaccines Market Report 2020-2030
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine...
Full DetailsPublished: 13 May 2021Vaccine Adjuvants Market Report 2021-2031
The opportunity for innovation within the vaccine adjuvants market remains strong. As time progresses, the technology used in the manufacturing...Full DetailsPublished: 02 February 2021Pre-Filled Syringes Market Report 2022-2032
With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market...Full DetailsPublished: 11 January 2022
Download sample pages
Complete the form below to download your free sample pages for Meningococcal Vaccines Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain pharma reports catalogue?
What are the dynamic growth sectors? where are the regional business opportunities?
Which technologies will prevail and who are the leading companies succeeding in these sectors and why?
If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.
If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032
Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.
26 January 2022
Visiongain Publishes Topical Drug Delivery Market Report 2022-2032
Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.
26 January 2022
Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032
The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.
24 January 2022
Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032
The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.
18 January 2022
